BOULDER, Colo., Jan. 8, 2015 /PRNewswire/ -- Array BioPharma
Inc. (Nasdaq: ARRY) today announced that its Chief Executive
Officer, Ron Squarer, will speak at
the Annual J.P. Morgan Healthcare Conference in San
Francisco. The public is welcome to participate in the
conference through a webcast on the Array BioPharma
website.
|
Event:
|
Annual J.P. Morgan
Healthcare Conference
|
|
Presenter:
|
Ron Squarer, Chief
Executive Officer, Array BioPharma
|
|
Date:
|
Wednesday, January
14, 2015
|
|
Time:
|
2:00 p.m. Pacific
Time
|
|
Location:
|
Westin St. Francis
Hotel, San Francisco
|
|
Webcast:
|
www.arraybiopharma.com
|
About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on
the discovery, development and commercialization of targeted small
molecule drugs to treat patients afflicted with cancer. Six
Phase 3 studies are currently enrolling patients. These programs
include two partnered cancer drugs, selumetinib (AstraZeneca) and
binimetinib (MEK162 / Novartis). For more information on
Array, please go to www.arraybiopharma.com.
|
CONTACT:
|
Tricia
Haugeto
|
|
Array BioPharma
Inc.
|
|
303-386-1193
|
|
thaugeto@arraybiopharma.com
|
Logo -
http://photos.prnewswire.com/prnh/20121029/LA02195LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/array-biopharma-to-present-at-the-annual-jp-morgan-healthcare-conference-300017985.html
SOURCE Array BioPharma Inc.